Get the Stockscreener App
0.9276
1.30%
-0.0122
Elutia Inc stock is traded at $0.9276, with a volume of 15,148.
It is down -1.30% in the last 24 hours and up +70.67% over the past month.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
See More
Previous Close:
$0.9398
Open:
$0.9
24h Volume:
15,148
Relative Volume:
0.04
Market Cap:
$39.50M
Revenue:
$24.38M
Net Income/Loss:
$-53.95M
P/E Ratio:
-0.3755
EPS:
-2.47
Net Cash Flow:
$-23.31M
1W Performance:
+10.13%
1M Performance:
+70.67%
6M Performance:
-51.69%
1Y Performance:
-68.56%
1-Day Range:
$0.90
$0.9422
1-Week Range:
$0.8101
$1.08
52-Week Range:
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.925 | 40.13M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
107.39 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.35 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.68 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.33 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.83 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Trend Review: Can Elutia Inc be recession proofJuly 2025 Review & Breakout Confirmation Trade Signals - baoquankhu1.vn
Aug Movers: Can OPCH scale operations efficientlyMarket Performance Report & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Elutia sees Q4 net sales of $3.3M - MSN
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Elutia reports 16% revenue growth, advances breast reconstruction product By Investing.com - Investing.com Nigeria
Elutia reports 16% revenue growth, advances breast reconstruction product - Investing.com
Elutia (ELUT) Strengthens Position with Drug-Eluting Platform - GuruFocus
Elutia reports preliminary fourth quarter 2025 results, strengthened financial position, and upcoming Nxt-41X milestones - marketscreener.com
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, And Upcoming Nxt-41X Milestones - TradingView — Track All Markets
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - The Manila Times
Press Release: Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones - 富途资讯
Elutia, Inc.Class A Common Stock (NQ: ELUT - FinancialContent
Elutia (NASDAQ:ELUT) Shares Up 4.7% – Should You Buy? - Defense World
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery - manilatimes.net
Elutia Inc. to Highlight NXT-41x Program at Inaugural Global BioInnovation Forum during JP Morgan Healthcare Conference - Quiver Quantitative
Breast reconstruction infections hit 25% of patients. A new approach emerges - Stock Titan
Why Elutia Inc. stock attracts high net worth investorsWeekly Profit Recap & Safe Entry Zone Tips - ulpravda.ru
Why Elutia Inc. stock could rally in 2025Weekly Volume Report & Weekly Momentum Stock Picks - Улправда
How Elutia Inc. stock reacts to job market dataMarket Volume Summary & Daily Risk Controlled Trade Plans - Улправда
Will Elutia Inc. stock gain from strong economy2025 Price Momentum & Daily Chart Pattern Signal Reports - ulpravda.ru
About Us | Oil & Gas JournalElutia, Inc.Class A Common Stock (Nasdaq:ELUT) Stock Quote - FinancialContent
Elutia Inc (ELUT) upgraded to buy: Here's what you should know - MSN
Gaithersburg biotech Elutia battles to keep Nasdaq listing after asset sale - The Business Journals
Where Analysts See Viviana Power Tech Limited Stock by YearEndTechnical Analysis Insights & Small Investment Growth Plans - earlytimes.in
Elutia Faces Nasdaq Noncompliance, Considers Options to Regain Listing - The Globe and Mail
Earnings Risk: Why Elutia Inc stock attracts high net worth investorsBond Market & Breakout Confirmation Alerts - moha.gov.vn
Elutia receives Nasdaq notice for non-compliance with market value and bid price rules - Investing.com India
Elutia Received Notice of Noncompliance - TradingView — Track All Markets
Elutia faces Nasdaq noncompliance, considers options to regain listing - MSN
ELUTIA INC (ELUT) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Is Elutia Stock Built to Withstand More Downside? - Trefis
Aug Volume: What insider trading reveals about Elutia Inc. stockQuarterly Earnings Report & Long-Term Safe Return Strategies - moha.gov.vn
Why Elutia Inc. stock remains a top recommendationWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
Is Elutia Inc. stock gaining market shareEarnings Risk Report & Expert Verified Stock Movement Alerts - Улправда
Published on: 2025-12-20 12:45:53 - Улправда
What insider trading reveals about Elutia Inc. stockBreakout Watch & Fast Gain Swing Alerts - Улправда
ELUT FinancialsIncome Statement - Quiver Quantitative
Is Elutia Inc. stock near bottom after decline2025 Performance Recap & High Return Trade Opportunity Guides - Улправда
Will Elutia Inc. stock deliver consistent dividendsM&A Rumor & Risk Controlled Daily Plans - ulpravda.ru
How risky is Elutia Inc. stock nowWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
[Form 4/A] ELUTIA INC. Amended Insider Trading Activity - Stock Titan
Insiders Make Bold Move on Elutia Stock With Fresh Buying Spree - TipRanks
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia (NASDAQ: ELUT) director reports purchase of 12,500 Class A shares - Stock Titan
Published on: 2025-12-19 04:35:35 - Улправда
ELUTIA Executives Increase Their Holdings - TradingView — Track All Markets
CFO Ferguson Buys 60,000 ($31.8K) Of Elutia Inc [ELUT] - TradingView — Track All Markets
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):